GT Biopharma
GTBP
GTBP
35 hedge funds and large institutions have $1.11M invested in GT Biopharma in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
63% less capital invested
Capital invested by funds: $3.05M → $1.11M (-$1.93M)
Holders
35
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$61.5K | |
| 2 | +$28.7K | |
| 3 | +$7.17K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$6.63K |
| 5 |
MCG
McCollum Christoferson Group
Amherst,
New York
|
+$5.46K |
Top Sellers
| 1 | -$1.21M | |
| 2 | -$21.9K | |
| 3 | -$20.4K | |
| 4 |
Jane Street
New York
|
-$9.4K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$8.75K |